Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialEugenio Mercuri, A. Nascimento, Nathalie Goemans et al.|The Lancet Neurology|2024Cited by 128
A Randomized, Double-Blind, Placebo-Controlled, Global Phase 3 Study of Edasalonexent in Pediatric Patients with Duchenne Muscular Dystrophy: Results of the PolarisDMD TrialRichard S. Finkel, Joanne M. Donovan, Craig M. McDonald et al.|Journal of Neuromuscular Diseases|2021Cited by 32
Long‐Term Evaluation of Givinostat in Duchenne Muscular Dystrophy, and Natural History ComparisonsCraig M. McDonald, Michela Guglieri, Dragana Vučinić et al.|Annals of Clinical and Translational Neurology|2025Cited by 12